Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference

EMERYVILLE, Calif., Sept. 6, 2023 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in a fireside chat at the H.C. Wainwright…

Click here to view original post